IMBED BIOSCIENCES INC
Ultrathin bioresorbable polymeric wound contact matrix impregnated with silver and gallium nanoparticles for biofilm dispersal in chronic wounds
- Sector
- Medtech
- Headquarters
- Madison, WI
- Founded
- 2010
- Latest Form D
- $3.5M, Dec 2023
- Total capital
- $24.1M
- Federal grants
- $5.3M
- 8 awards · 2015–2021
- Rank in peer group#400 of 538
- Private capital raised
- $18.8M
- 8 Form D · last Dec 2023
- 34 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 3
- 9 pending · first 2021
- Rank in peer group#158 of 538
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 8th filing$3.5M
- Private capital raisedForm D · SEC · 7th filing$2.5M
- Private capital raisedForm D · SEC · 6th filing$7.9M
- Federal grantHealth and Human S · Phase II · Ultrathin dissolvable antibiofilm wound contact dressing with silver and gallium$806K
- Federal grantHealth and Human S · Phase II · Ultrathin Dissolvable Antibiofilm Wound Contact Dressing with Silver and Gallium$158K
- Federal grantHealth and Human S · Phase II · Ultrathin dissolvable antibiofilm wound contact dressing with silver and gallium$749K
- Private capital raisedForm D · SEC · 5th filing$1.5M
- Private capital raisedForm D · SEC · 4th filing$1.1M
- Private capital raisedForm D · SEC · 3rd filing$1.6M
- Private capital raisedForm D · SEC · 2nd filing$600K
- Private capital raisedForm D · SEC · 1st filing$180K
Show 5 earlier federal awards
- Federal grantHealth and Human S · Phase II · Ultrathin Dissolvable Antibiofilm Wound Contact Dressing with Silver and Gallium$1.7M
- Federal grantHealth and Human S · Phase II · Ultrathin dissolvable antibiofilm wound contact dressing with silver and gallium$747K
- Federal grantHealth and Human S · Phase I · Ultrathin dissolvable antibiofilm wound contact dressing with silver and gallium$225K
- Federal grantHealth and Human S · Phase I · Ultrathin dissolvable antibiofilm wound contact dressing with silver and gallium$225K
- Federal grantHealth and Human S · Phase II · Antibacterial molecular coatings pre-fabricated for biologic wound dressings$725K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 538 peers
Line = medianMedtech · Device
- Federal grantsBelow median
- Granted patents#158 · top 29%
- Linked publications#46 · top 9%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Ankit AgarwalResearcherExecutive Officer, DirectorLinked by 2 patents · $5.3M in grants as PI
- Charles J CzuprynskiDirectorNamed in SEC Form D filings
- David GuintherDirectorNamed in SEC Form D filings
- Elizabeth B. TaylorDirectorNamed in SEC Form D filings
- Jeff J. HansonDirectorNamed in SEC Form D filings
- Jonathan BlackExecutive Officer, DirectorNamed in SEC Form D filings
Show all 11 people
- Michael J SchurrDirectorNamed in SEC Form D filings
- Nicholas L AbbottExecutive Officer, DirectorNamed in SEC Form D filings
- Philip FosterDirectorNamed in SEC Form D filings
- Robert A. BeckmanDirectorNamed in SEC Form D filings
- Walter DeweyDirectorNamed in SEC Form D filings
What it has protected
USPTO · 3 granted of 12- PendingMethods And Compositions For Wound HealingUSPTOApplication 19322800
- GrantedMethods And Compositions For Wound HealingUSPTOUS 12,409,247
- GrantedMethods And Compositions For Wound HealingUSPTOUS 11,554,194
Show all 12 patent records
- Methods And Compositions For Wound HealingJan 1, 2026 · Application 19322800Pending
- Methods And Compositions For Wound HealingSep 9, 2025 · US 12,409,247Granted
- Methods And Compositions For Wound HealingJan 17, 2023 · US 11,554,194Granted
- Methods And Compositions For Wound HealingJun 24, 2021 · Application 17193023Pending
- Methods And Compositions For Wound HealingMar 9, 2021 · US 10,940,120Granted
- Methods And Compositions For Wound HealingFeb 4, 2016 · Application 14882913Pending
- Methods And Compositions For Wound HealingOct 8, 2015 · Application 14440997Pending
- Methods And Compositions For Wound HealingApplication PCTUS2013068463Pending
- Wound Dressings Containing An Antimicrobial Silver Composition And An Analgesic CompoundApplication 63705807Pending
- Silver Nanoparticles For Use In Inhibiting And Treating Coronavirus InfectionApplication 63005727Pending
- Methods And Compositions For Wound HealingApplication PCTUS2017044418Pending
- Wound Dressings Containing An Antimicrobial Silver Composition And An Analgesic CompoundApplication PCTUS2025050444Pending
Recent research by its founders
- Accuracy of a Smart-Ring VO2max Estimate and Five Published Prediction Equations Against Cardiopulmonary Exercise Testing: Development and Validation Study With Population-Scale Analysis20260 cites
- Correlation of Arterial Blood Gas Parameters with the Duration of Proning in Awake Non-intubated COVID-19 Patients- A Retrospective Observational Study20260 cites
- “Development and validation towards a Nomogram to predict acute kidney Injury following PCNL”20254 cites
Related companies, and why
- ACTIVITY RHYTHM SOLUTIONS CORPORATIONSimilar federal contract value in Medtech · null in contracts
- StimuSIL, Inc.Similar federal contract value in Medtech · null in contracts
- GENETAG TECHNOLOGY, INCSimilar federal contract value in Medtech · null in contracts
- Cadense, Inc.Similar federal contract value in Medtech · null in contracts
- Pulse Therapeutics, Inc.Similar federal contract value in Medtech · null in contracts
- VascuLogic LLCSimilar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .